Drug
Treximet
Treximet is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Phase Distribution
Ph phase_2
1
17%
Ph phase_3
1
17%
Ph not_applicable
1
17%
Ph phase_4
3
50%
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Other(1)
Detailed Status
Completed5
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 43 (50.0%)
N/A1 (16.7%)
Trials by Status
unknown117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_4
Ictal and Interictal Inflammatory Markers in Migraine
NCT01138150
completedphase_2
Treximet Early Intervention Adolescent Migraine
NCT01016678
completedphase_4
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
NCT01329562
completedphase_4
Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
NCT01450995
completedphase_3
TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
NCT00573170
Clinical Trials (6)
Showing 6 of 6 trials
NCT01138150Phase 4
Ictal and Interictal Inflammatory Markers in Migraine
NCT01016678Phase 2
Treximet Early Intervention Adolescent Migraine
NCT01329562Phase 4
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
NCT01450995Phase 4
Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
NCT00573170Phase 3
TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
NCT00837044Not Applicable
Treximet in Acute Migraine Headache: Assessing Cognitive Function
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6